Ally Bridge Group (Ny) LLC Portfolio Holdings

Ally Bridge Group (Ny) LLC

  • $141 Million
  • Q3 2024

Ally Bridge Group (Ny) LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $141 Million distributed in 29 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Insmed Inc with a value of $11M, Tarsus Pharmaceuticals, Inc. with a value of $10.6M, Merus N.V. with a value of $10.4M, Blueprint Medicines Corp with a value of $9.81M, and Sarepta Therapeutics, Inc. with a value of $8.99M.

Examining the 13F form we can see an increase of $34M in the current position value, from $107M to 141M.

Ally Bridge Group (Ny) LLC is based out at New York, NY

Below you can find more details about Ally Bridge Group (Ny) LLC portfolio as well as his latest detailed transactions.

Portfolio value $141 Million
Healthcare: $139 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11.1B
$8.99 Million 6.39% of portfolio
72,000
Q3 2024 Reduced 2.04%

Summary

  • Portfolio
  • No. of Stocks 29
  • Current Value $141 Million
  • Prior Value $107 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 9 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email